의약품 제조 시장 규모, 점유율, 성장 분석 : 제형별, 투여 경로별, 처방 유형별, 처방 유형별, 의약품 개발별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Pharmaceutical Manufacturing Market Size, Share, Growth Analysis, By Formulation Type, By Route of Administration, By Prescription Type, By Drug Development, By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1622326
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
제약 제조 시장 규모는 2023년 5,720억 9,000만 달러로 2024년 6,630억 5,000만 달러에서 2032년 2조 1,588억 2,000만 달러로 예측 기간(2025-2032년) 동안 15.9%의 CAGR로 성장할 것으로 예상됩니다.
세계 의약품 제조 시장은 중요한 의료 수요와 연구, 개발 및 의약품 생산의 증가로 인해 여전히 견조한 성장세를 보이고 있습니다. 주요 성장 요인으로는 인구 증가, 만성질환 유병률 증가, 의료기술의 눈부신 발전 등을 들 수 있습니다. 혁신적인 의약품, 맞춤형 치료 및 생물학적 제제의 추구는 시장의 역동성을 더욱 강화하고 있습니다. 또한, 의료 인프라의 확대, 의료 접근성 향상을 위한 정부의 노력, 제조 시설에 대한 투자 증가가 시장 성장을 촉진하고 있습니다. 그러나 이 분야는 엄격한 규제 프레임워크, 가격 압력, 지적재산권 문제 등 전반적인 발전을 저해할 수 있는 도전 과제에 직면해 있습니다. 이러한 복잡한 상황은 제약 업계의 이해관계자들에게 기회와 도전을 동시에 가져다주고 있습니다.
목차
소개
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장 가정과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porters 분석
주요 시장 인사이트
핵심성공요인
경쟁 정도
주요 투자 기회
시장 생태계
시장 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
특허 분석
사례 연구
고객과 구매 기준 분석
무역 분석
의약품 제조 시장 규모 : 제제 유형별 & CAGR(2025-2032)
시장 개요
경구 제제
정제
캡슐
분말
주사제
액체 주사
동결건조 주사제
국소용 제제
크림
연고
젤
흡입 제제
드라이 파우더 흡입기(DPI)
정량 분무식 흡입기(MDI)
기타
좌약
패치
의약품 제조 시장 규모 : 투여 경로별 & CAGR(2025-2032)
시장 개요
경구
비경구
국소
흡입
경피
기타
의약품 제조 시장 규모 : 처방 유형별 & CAGR(2025-2032)
시장 개요
처방약
시판약(OTC)
의약품 제조 시장 규모 : 의약품 개발별 & CAGR(2025-2032)
시장 개요
전임상 개발
임상시험
단계 I
단계 II
단계 III
규제 당국 승인
상업 생산
의약품 제조 시장 규모 : 유통 채널별 & CAGR(2025-2032)
시장 개요
병원 약국
소매 약국
온라인 약국
기타
의약품 제조 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5개사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년비 비교(2022-2024)
주요 기업 개요
Pfizer Inc.(USA)
Novartis AG(Switzerland)
Roche Holding AG(Switzerland)
Sanofi S.A.(France)
Merck & Co., Inc.(USA)
GlaxoSmithKline plc(UK)
Johnson & Johnson(USA)
AstraZeneca plc(UK)
Eli Lilly and Company(USA)
AbbVie Inc.(USA)
Bristol-Myers Squibb Company(USA)
Bayer AG(Germany)
Amgen Inc.(USA)
Gilead Sciences, Inc.(USA)
Takeda Pharmaceutical Company Limited(Japan)
Boehringer Ingelheim GmbH(Germany)
Teva Pharmaceutical Industries Ltd.(Israel)
Novo Nordisk A/S(Denmark)
Astellas Pharma Inc.(Japan)
CSL Limited(Australia)
결론과 추천사항
ksm
영문 목차
영문목차
Pharmaceutical Manufacturing Market size was valued at USD 572.09 Billion in 2023 and is poised to grow from USD 663.05 Billion in 2024 to USD 2158.82 Billion by 2032, growing at a CAGR of 15.9% during the forecast period (2025-2032).
The global pharmaceutical manufacturing market remains robust, driven by essential healthcare demands and a surge in research, development, and drug production. Key growth factors include an increasing population, a rising incidence of chronic diseases, and significant advancements in medical technology. The pursuit of innovative drugs, personalized treatments, and biologics is further enhancing market dynamics. Additionally, the expansion of healthcare infrastructure, government initiatives aimed at improving healthcare access, and rising investments in manufacturing facilities are fueling market growth. Nevertheless, the sector faces challenges such as stringent regulatory frameworks, pricing pressures, and intellectual property rights issues that could hinder overall progress. This complex landscape presents both opportunities and hurdles for stakeholders in the pharmaceutical industry.
Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmaceutical Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Manufacturing Market is segmented by formulation type, route of administration, prescription type, drug development, distribution channel and region. Based on formulation type, the market is segmented into oral formulations, injectable formulations, topical formulations, inhalation formulations and others. Based on route of administration, the market is segmented into oral, parenteral, topical, inhalation, transdermal and others. Based on prescription type, the market is segmented into prescription drugs and over-the-counter (OTC) drugs. Based on drug development, the market is segmented into preclinical development, clinical trials, regulatory approval and commercial manufacturing. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Pharmaceutical Manufacturing Market
A key driver of the global pharmaceutical manufacturing market is the escalating demand for healthcare products and medications across the globe. The expanding global population, combined with a rise in chronic diseases and infectious conditions, has sparked a significant increase in the need for pharmaceuticals. Furthermore, advancements in medical technology and a growing aging demographic further elevate the demand for new and innovative treatments. In response to this escalating market need, pharmaceutical manufacturers are compelled to enhance their production capacities, invest in research and development, and implement cutting-edge manufacturing technologies, ultimately fostering robust market growth.
Restraints in the Pharmaceutical Manufacturing Market
A significant challenge facing the pharmaceutical manufacturing market is the stringent regulatory framework enforced by governments and regulatory agencies. These bodies mandate rigorous standards to ensure the safety, efficacy, and quality of pharmaceutical products, demanding substantial investments in infrastructure, quality assurance processes, and meticulous documentation. Failure to comply with these regulations can lead to severe penalties and tarnish a company's reputation. Additionally, the intricate and lengthy approval process for new drugs can slow down product launches, ultimately delaying access to vital medications for patients. These regulatory hurdles create barriers for new entrants and elevate the overall costs and timelines associated with pharmaceutical manufacturing.
Market Trends of the Pharmaceutical Manufacturing Market
The global pharmaceutical manufacturing market is experiencing a significant trend towards personalized medicine and targeted therapies, fueled by technological advancements in genomics and a demand for individualized treatments. This shift has prompted manufacturers to adapt by embracing smaller batch production and flexible manufacturing processes. Concurrently, the focus on biologics and biosimilars is intensifying due to the growing prevalence of chronic diseases and the pursuit of innovative therapeutic solutions. Sustainability also plays a crucial role, as pharmaceutical companies increasingly prioritize eco-friendly practices, waste reduction, and energy efficiency to comply with stringent environmental regulations and align with evolving consumer expectations.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies
Customer & Buying Criteria Analysis
Trade Analysis
Global Pharmaceutical Manufacturing Market Size by Formulation Type & CAGR (2025-2032)
Market Overview
Oral Formulations
Tablets
Capsules
Powders
Injectable Formulations
Liquid Injections
Lyophilized Injections
Topical Formulations
Creams
Ointments
Gels
Inhalation Formulations
Dry Powder Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Others
Suppositories
Patches
Global Pharmaceutical Manufacturing Market Size by Route of Administration & CAGR (2025-2032)
Market Overview
Oral
Parenteral
Topical
Inhalation
Transdermal
Others
Global Pharmaceutical Manufacturing Market Size by Prescription Type & CAGR (2025-2032)
Market Overview
Prescription Drugs
Over-The-Counter (OTC) Drugs
Global Pharmaceutical Manufacturing Market Size by Drug Development & CAGR (2025-2032)
Market Overview
Preclinical Development
Clinical Trials
Phase I
Phase II
Phase III
Regulatory Approval
Commercial Manufacturing
Global Pharmaceutical Manufacturing Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Pharmaceutical Manufacturing Market Size & CAGR (2025-2032)
North America (Formulation Type, Route of Administration, Prescription Type, Drug Development, Distribution Channel)
US
Canada
Europe (Formulation Type, Route of Administration, Prescription Type, Drug Development, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Formulation Type, Route of Administration, Prescription Type, Drug Development, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Formulation Type, Route of Administration, Prescription Type, Drug Development, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Formulation Type, Route of Administration, Prescription Type, Drug Development, Distribution Channel)
